{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:48:44Z","timestamp":1790160524251,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005687","name":"Goethe-Universit\u00e4t Frankfurt am Main","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.tranon.2020.100785","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T13:13:06Z","timestamp":1589375586000},"page":"100785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"13","author":[{"given":"Jana","family":"Lippmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Fulda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Liese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2020.100785_bb0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tranon.2020.100785_bb0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2020.100785_bb0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.24064","article-title":"Tumor resistance to apoptosis","volume":"124","author":"Fulda","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2020.100785_bb0020","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2020.100785_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2020.100785_bb0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tranon.2020.100785_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.208","article-title":"Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells","volume":"7","author":"Ma","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2020.100785_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: a novel anti-tumor action for cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.tranon.2020.100785_bb0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18632\/oncoscience.160","article-title":"Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells","volume":"2","author":"Eling","year":"2015","journal-title":"Oncoscience"},{"key":"10.1016\/j.tranon.2020.100785_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tranon.2020.100785_bb0055","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1172\/JCI99032","article-title":"Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma","volume":"128","author":"Hassannia","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2020.100785_bb0060","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10495-017-1424-9","article-title":"Induction of reactive oxygen species: an emerging approach for cancer therapy","volume":"22","author":"Zou","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.tranon.2020.100785_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","article-title":"Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death","volume":"8","author":"Seiler","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.tranon.2020.100785_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.molmed.2017.03.004","article-title":"ROS in cancer: the burning question","volume":"23","author":"Chio","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tranon.2020.100785_bb0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2020.100785_bb0080","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.30467","article-title":"Induction of oxidative stress via inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2020.100785_bb0085","doi-asserted-by":"crossref","first-page":"20096","DOI":"10.1074\/jbc.273.32.20096","article-title":"Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds","volume":"273","author":"Gromer","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2020.100785_bb0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2020.100785_bb0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.tranon.2020.100785_bb0100","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2020.100785_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bcp.2016.08.011","article-title":"Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells","volume":"118","author":"Lange","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tranon.2020.100785_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2015.04.018","article-title":"Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells","volume":"365","author":"Liese","year":"2015","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.tranon.2020.100785_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/CAD.0000000000000750","article-title":"Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells","volume":"30","author":"Liese","year":"2019","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.tranon.2020.100785_bb0120","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2020.100785_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2020.100785_bb0130","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2017.07.136","article-title":"Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells","volume":"491","author":"Bai","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tranon.2020.100785_bb0135","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41419-018-1063-2","article-title":"A pharmacological probe identifies cystathionine beta-synthase as a new negative regulator for ferroptosis","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2020.100785_bb0140","first-page":"3823","article-title":"The CD95 (APO-1\/Fas) system mediates drug-induced apoptosis in neuroblastoma cells","volume":"57","author":"Fulda","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2020.100785_bb0145","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tranon.2020.100785_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0262-1746(84)90102-1","article-title":"Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets","volume":"13","author":"Salari","year":"1984","journal-title":"Prostaglandins Leukot Med"},{"key":"10.1016\/j.tranon.2020.100785_bb0155","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1016\/j.bmc.2006.01.057","article-title":"Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases","volume":"14","author":"Deschamps","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tranon.2020.100785_bb0160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0891-5849(02)00848-1","article-title":"C11-BODIPY(581\/591), an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology","volume":"33","author":"Drummen","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tranon.2020.100785_bb0165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0014-5793(99)00696-1","article-title":"Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581\/591)","volume":"453","author":"Pap","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tranon.2020.100785_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2011.09.030","article-title":"Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations","volume":"52","author":"Kalyanaraman","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tranon.2020.100785_bb0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-12-416618-9.00013-3","article-title":"Methods to monitor ROS production by fluorescence microscopy and fluorometry","volume":"542","author":"Wojtala","year":"2014","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.tranon.2020.100785_bb0180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.biopha.2005.06.005","article-title":"Alpha-tocopherol: roles in prevention and therapy of human disease","volume":"59","author":"Tucker","year":"2005","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2020.100785_bb0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20130282","article-title":"ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors","volume":"454","author":"Halasi","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.tranon.2020.100785_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4161\/cbt.9.2.10583","article-title":"N-acetylcysteine, reactive oxygen species and beyond","volume":"9","author":"Sun","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tranon.2020.100785_bb0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.bi.54.070185.001321","article-title":"Thioredoxin","volume":"54","author":"Holmgren","year":"1985","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.tranon.2020.100785_bb0200","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","article-title":"Glutathione peroxidases","volume":"1830","author":"Brigelius-Flohe","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tranon.2020.100785_bb0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fonc.2017.00117","article-title":"Escaping death: mitochondrial redox homeostasis in cancer cells","volume":"7","author":"Ciccarese","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2020.100785_bb0210","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tranon.2020.100785_bb0215","article-title":"Emerging strategies of cancer therapy based on ferroptosis","volume":"30","author":"Shen","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tranon.2020.100785_bb0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fonc.2015.00131","article-title":"Oncogenic RAS mutants confer resistance of RMS13 rhabdomyosarcoma cells to oxidative stress-induced ferroptotic cell death","volume":"5","author":"Schott","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2020.100785_bb0225","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.2174\/1381612821666151029112126","article-title":"Cross-talk between TGF-beta and NADPH oxidases during liver fibrosis and hepatocarcinogenesis","volume":"21","author":"Crosas-Molist","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tranon.2020.100785_bb0230","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.redox.2015.07.005","article-title":"Role of NADPH oxidases in the redox biology of liver fibrosis","volume":"6","author":"Crosas-Molist","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.tranon.2020.100785_bb0235","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.18632\/oncotarget.13904","article-title":"Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis","volume":"8","author":"Ivanov","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2020.100785_bb0240","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.3892\/ol.2015.3621","article-title":"Mitochondrial reactive oxygen species and complex II levels are associated with the outcome of hepatocellular carcinoma","volume":"10","author":"Wu","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2020.100785_bb0245","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1158\/1535-7163.MCT-12-0093","article-title":"Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo","volume":"11","author":"Coriat","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tranon.2020.100785_bb0250","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1158\/0008-5472.CAN-10-1509","article-title":"Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation","volume":"70","author":"Mandal","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2020.100785_bb0255","doi-asserted-by":"crossref","first-page":"22244","DOI":"10.1074\/jbc.M110.121327","article-title":"System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency","volume":"285","author":"Mandal","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2020.100785_bb0260","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tranon.2020.100785_bb0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","article-title":"Auranofin: repurposing an old drug for a golden new age","volume":"15","author":"Roder","year":"2015","journal-title":"Drugs R D"},{"issue":"5","key":"10.1016\/j.tranon.2020.100785_bb0270","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/1878-0261.12476","article-title":"Targeting the thioredoxin system as a novel strategy against B cell acute lymphoblastic leukemia","volume":"13","author":"Fidyt","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.tranon.2020.100785_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.412","article-title":"Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death","volume":"8","author":"Habermann","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2020.100785_bb0280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/ars.2016.6841","article-title":"Targeting of the glutathione, thioredoxin, and Nrf2 antioxidant systems in head and neck cancer","volume":"27","author":"Roh","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tranon.2020.100785_bb0285","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2020.100785_bb0290","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1667\/RR14463.1","article-title":"Enhancement of radiation response in breast cancer stem cells by inhibition of thioredoxin- and glutathione-dependent metabolism","volume":"186","author":"Rodman","year":"2016","journal-title":"Radiat. Res."},{"key":"10.1016\/j.tranon.2020.100785_bb0295","first-page":"1739","article-title":"Pilot study of intravenous melphalan combined with continuous infusion L-S","volume":"62","author":"Anderson","year":"2015","journal-title":"R-buthionine sulfoximine for children with recurrent neuroblastoma, Pediatr Blood Cancer"},{"key":"10.1016\/j.tranon.2020.100785_bb0300","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/pbc.25994","article-title":"A Phase I new approaches to neuroblastoma therapy study of buthionine sulfoximine and melphalan with autologous stem cells for recurrent\/refractory high-risk neuroblastoma","volume":"63","author":"Villablanca","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.tranon.2020.100785_bb0305","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.27790","article-title":"Nrf2, but not beta-catenin, mutation represents an early event in rat hepatocarcinogenesis","volume":"62","author":"Zavattari","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2020.100785_bb0310","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.27828","article-title":"NRF2\/KEAP1 and Wnt\/beta-catenin in the multistep process of liver carcinogenesis in humans and rats","volume":"62","author":"Nault","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2020.100785_bb0315","series-title":"A Dual Role of Heme Oxygenase-1 in Cancer Cells, Int J Mol Sci, 20","author":"Chiang","year":"2018"},{"key":"10.1016\/j.tranon.2020.100785_bb0320","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ejca.2009.12.025","article-title":"The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms","volume":"46","author":"Llobet","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tranon.2020.100785_bb0325","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2020.100785_bb0330","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.canlet.2014.11.014","article-title":"The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells","volume":"356","author":"Louandre","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2020.100785_bb0335","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.1111\/jcmm.14594","article-title":"Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells","volume":"23","author":"Bai","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tranon.2020.100785_bb0340","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.18632\/oncotarget.23843","article-title":"Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells","volume":"9","author":"Sauzay","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2020.100785_bb0345","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2020.100785_bb0350","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/15548627.2018.1503146","article-title":"Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523320300218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523320300218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:38:23Z","timestamp":1761835103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523320300218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1936523320300218"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2020.100785","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2020.100785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100785"}}